Xingchen Zhou
Jinan, 250033, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Impact of Clonal Hematopoiesis of Indeterminate Potential on Treatment Response and Tumor Microenvironment in Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy.
Journal: Journal of mammary gland biology and neoplasia
Published: October 10, 2025
TACC3, correlated with immune cell infiltrates, is a novel prognostic biomarker in BRCA.
Journal: Medicine
Published: May 22, 2025
Label-free Raman spectroscopy reveals tumor microenvironmental changes induced by intermittent fasting for the prevention of breast cancer in animal model.
Journal: Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy
Published: December 30, 2023
Integrated multi-omics profiling reveals a clinically relevant molecular feature and potential therapeutic target on phyllodes tumors of breast.
Journal: Translational oncology
Published: December 29, 2023
Relevance Analysis of TPM2 and Clinicopathological Characteristics in Breast Cancer.
Journal: International journal of general medicine
Published: October 07, 2023
CENPF knockdown inhibits adriamycin chemoresistance in triple-negative breast cancer via the Rb-E2F1 axis.
Journal: Scientific reports
Published: October 06, 2022
Alterations of biomarker profiles after neoadjuvant chemotherapy in breast cancer: tumor heterogeneity should be taken into consideration.
Journal: Oncotarget
Published: May 31, 2015
Over expression of hRad9 protein correlates with reduced chemosensitivity in breast cancer with administration of neoadjuvant chemotherapy.
Journal: Scientific reports
Published: March 31, 2014
Showing 1-9 of 9
Last Updated: 09/26/2026